DOTmed October 25, 2024
Lauren Dubinsky

GE HealthCare and the University of Medicine Essen are partnering to create a Theranostics Center of Excellence in Europe.

“Theranostics is helping provide a pathway to hope in treating advanced-stage cancer,” Jean-Luc Procaccini, president and CEO of Molecular Imaging and Computed Tomography at GE HealthCare, told HCB News. “Offering a personalized approach that uses both diagnosis and therapy as part of the treatment, it helps clinicians leverage diagnostics and enables more accurate disease staging and treatment delivery.”

One of the goals of this collaboration is to bolster production of and access to radioisotopes to be used for precise disease diagnoses and monitoring. GE HealthCare has plans to equip the university’s new tracer development center with radiopharmacy technology including a cyclotron,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry
Cala Health Snags $50M for At-Home Tremor Relief Therapy

Share This Article